Zdrowie i gospodarka · 11/04/2011

FDA Clears FENTORA Buccal Tablet for Approval, Despite Safety Concerns

The Food and Drug Administration (FDA) has determined that FENTORA (fentanyl citrate) buccal tablet, 300 micrograms, was not withdrawn from sale for reasons of safety or effectiveness, paving the way for potential approval of the medication through abbreviated new drug applications (ANDAs)